Literature DB >> 33946145

The Role of Left-Atrial Mechanics Assessed by Two-Dimensional Speckle-Tracking Echocardiography to Differentiate Hypertrophic Cardiomyopathy from Hypertensive Left-Ventricular Hypertrophy.

Nicoleta-Monica Popa-Fotea1,2, Miruna Mihaela Micheu2, Nicoleta Oprescu2, Adriana Alexandrescu2, Maria Greavu3, Sebastian Onciul1,2, Roxana Onut2, Ioana Petre1,2, Alina Scarlatescu2, Monica Stoian2, Razvan Ticulescu3, Diana Zamfir2, Maria Dorobanțu1,2.   

Abstract

Hypertrophic cardiomyopathy (HCM) and arterial hypertension (HTN) are conditions with different pathophysiology, but both can result in left-ventricular hypertrophy (LVH). The role of left-atrial (LA) functional changes detected by two-dimensional speckle-tracking echocardiography (STE) in indicating LVH etiology is unknown.
METHODS: We aimed to characterize LA mechanics using STE in LVH patients with HCM and HTN. LA 2D volumetric and STE parameters were analyzed in 86 LVH patients (43 HCM and 43 isolated HTN subjects) and 33 age- and sex-matched controls.
RESULTS: The volumetric study showed that LA reservoir and conduit function were impaired in the HCM group compared to controls, while, in the HTN group, only LA conduit function was deteriorated. The HCM group had all three STE-derived LA functions impaired compared to controls. The HTN group, consistently with volumetric analysis, had solely LA conduit function reduced compared to controls. Ratios of LA booster-pump strain (S) and strain rate (SR) to interventricular septum (IVS) thickness were the most accurate parameters to discriminate between HCM and HTN. The subgroup harboring sarcomeric pathogenic (P)/likely pathogenic (LP) variants had reduced LA booster-pump S and SR compared with the genotype-negative subgroup.
CONCLUSIONS: LA reservoir, conduit, and pump functions are decreased in HCM compared to HTN patients with similar LVH. We report the ratios between LA contraction S/SR and IVS thickness as novel parameters with high accuracy in discriminating LVH due to HCM. The presence of P/LP variants in sarcomeric or sarcomeric-associated genes could be associated with more severe LA dysfunction.

Entities:  

Keywords:  hypertrophic cardiomyopathy; left-atrial function; left-ventricular hypertrophy; sarcomeric genes; sarcomeric-associated genes; speckle-tracking echocardiography

Year:  2021        PMID: 33946145     DOI: 10.3390/diagnostics11050814

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  30 in total

Review 1.  Left ventricular hypertrophy in hypertension: its arrhythmogenic potential.

Authors:  Thomas Kahan; Lennart Bergfeldt
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

2.  Feasibility of strain and strain rate imaging for the assessment of regional left atrial deformation: a study in normal subjects.

Authors:  C Sirbu; L Herbots; J D'hooge; P Claus; A Marciniak; T Langeland; B Bijnens; F E Rademakers; G R Sutherland
Journal:  Eur J Echocardiogr       Date:  2005-07-28

3.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  J Am Soc Echocardiogr       Date:  2015-01       Impact factor: 5.251

Review 4.  New echocardiographic techniques for evaluation of left atrial mechanics.

Authors:  Maria Chiara Todaro; Indrajit Choudhuri; Marek Belohlavek; Arshad Jahangir; Scipione Carerj; Lilia Oreto; Bijoy K Khandheria
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-08-21       Impact factor: 6.875

5.  Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.

Authors:  Johannes T Kowallick; Miguel Silva Vieira; Shelby Kutty; Joachim Lotz; Gerd Hasenfu; Amedeo Chiribiri; Andreas Schuster
Journal:  Invest Radiol       Date:  2017-03       Impact factor: 6.016

6.  Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity.

Authors:  Hua Yang; Anna Woo; Daniel Monakier; Michal Jamorski; Katie Fedwick; E Douglas Wigle; Harry Rakowski
Journal:  J Am Soc Echocardiogr       Date:  2005-10       Impact factor: 5.251

7.  Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry.

Authors:  Steven D Colan; Steven E Lipshultz; April M Lowe; Lynn A Sleeper; Jane Messere; Gerald F Cox; Paul R Lurie; E John Orav; Jeffrey A Towbin
Journal:  Circulation       Date:  2007-01-29       Impact factor: 29.690

Review 8.  Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review.

Authors:  Liza Thomas; Thomas H Marwick; Bogdan A Popescu; Erwan Donal; Luigi P Badano
Journal:  J Am Coll Cardiol       Date:  2019-04-23       Impact factor: 24.094

9.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors:  Perry M Elliott; Aris Anastasakis; Michael A Borger; Martin Borggrefe; Franco Cecchi; Philippe Charron; Albert Alain Hagege; Antoine Lafont; Giuseppe Limongelli; Heiko Mahrholdt; William J McKenna; Jens Mogensen; Petros Nihoyannopoulos; Stefano Nistri; Petronella G Pieper; Burkert Pieske; Claudio Rapezzi; Frans H Rutten; Christoph Tillmanns; Hugh Watkins
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

10.  Left atrial function in diastolic heart failure.

Authors:  Mustafa Kurt; Jianwen Wang; Guillermo Torre-Amione; Sherif F Nagueh
Journal:  Circ Cardiovasc Imaging       Date:  2009-01       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.